| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |